{"filings":[{"id":104572,"accession_number":"0001493712-26-000006","cik":1493712,"company_name":"Stimcell Energetics Inc.","ticker":"STME","form_type":"8-K","filed_at":"2026-03-20T23:59:59+00:00","items":["1.01","3.02","7.01","1.1","9.01"],"status":"ready","headline":"StimCell Energetics engages Stonegate Capital Partners for research coverage; issues 250,000 shares","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Stonegate will provide quarterly research, IR consultation, and institutional investor meetings for 12-month term.","Compensation: 250,000 shares of common stock issued under Rule 506(b) to accredited investor Stonegate.","Shares subject to 6-month hold period in Canada and restricted under U.S. securities laws.","Company seeks to boost institutional ownership and visibility for its eBalance technology."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"market_cap_usd":6765207.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":120844,"accession_number":"0001493712-25-000005","cik":1493712,"company_name":"Stimcell Energetics Inc.","ticker":"STME","form_type":"8-K","filed_at":"2025-12-02T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"StimCell signs research agreement with St. Boniface Hospital to study eBalance on mitochondrial function","summary_kind":"llm","event_type":"other_material","confidence":"medium","bullets":["Service agreement with St. Boniface Hospital Albrechtsen Research Centre, effective Dec 1, 2025.","Study will examine eBalance® microcurrent device effects on mitochondrial function in sensory neurons.","Principal Investigator Prof. Paul Fernyhough; project expected to last approximately three months.","Measurements include oxygen consumption rates, ATP production, glycolysis, and enzyme activities."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"market_cap_usd":6765207.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":173285,"accession_number":"0001139020-25-000008","cik":1493712,"company_name":"Stimcell Energetics Inc.","ticker":"STME","form_type":"8-K","filed_at":"2025-03-28T23:59:59+00:00","items":["1.01","3.02","7.01","9.01"],"status":"ready","headline":"StimCell Energetics settles $15K debt with shares, engages Rain Communications for IR, and previews eBalance redesign","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Settled $15,000 debt via 75,000 common shares at $0.20 per share.","Engaged Rain Communications for eight-month IR; will receive 125,000 shares/month at $0.20 each.","eBalance redesign v1 revealed: smaller device with custom iOS/Android app for personalized treatment tracking.","Shares issued under Regulation S and Rule 506(b); four-month hold period in Canada."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":6765207.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":173284,"accession_number":"0001393905-25-000075","cik":1493712,"company_name":"Stimcell Energetics Inc.","ticker":"STME","form_type":"8-K","filed_at":"2025-02-27T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"StimCell Energetics partners with ADM Tronics to redesign eBalance device for home use","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Partnership with ADM Tronics (OTCQB: ADMT) to redesign eBalance microcurrent device for home use.","Redesigned unit will be smaller, cost-effective, and include real-time cellular energy diagnostics, treatment tracking, and personalized profiles.","eBalance uses non-invasive frequency-specific microcurrent to stimulate ATP production for anti-aging, pain relief, and vitality.","CEO David Jeffs says redesign aims to make cellular energy optimization accessible for home users."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":6765207.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":173283,"accession_number":"0001393905-25-000013","cik":1493712,"company_name":"Stimcell Energetics Inc.","ticker":"STME","form_type":"8-K","filed_at":"2025-01-08T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"StimCell Energetics engages Think Ink Marketing for six-month investor outreach","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Signs marketing services agreement with Think Ink Marketing Data & Email Services, Inc.","Agreement runs six months; either party may terminate with 30 days' notice.","Budget up to $10,000 per month for online banners and native ads.","Company completed rebranding; now trades under symbol STME on OTC.","Think Ink is a California-based marketing firm established in 1991."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"market_cap_usd":6765207.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":190302,"accession_number":"0001393905-24-000378","cik":1493712,"company_name":"Stimcell Energetics Inc.","ticker":"STME","form_type":"8-K","filed_at":"2024-11-05T23:59:59+00:00","items":["5.03","8.01","9.01"],"status":"ready","headline":"Cell MedX completes 1:15 reverse stock split and rebrands as Stimcell Energetics","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Reverse split 1:15 effective Nov 1, 2024; shares outstanding reduced from ~297M to ~19.8M.","Authorized capital reduced from 7.5B to 500M shares of common, par value $0.001.","Name changed from Cell MedX Corp. to Stimcell Energetics Inc.","Symbol will trade as \"CMXCD\" for 20 business days starting Nov 5, then seek new symbol.","New website launched at www.StimCell.com for investor and clinical trial info."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.45,"calibrated_materiality_score":0.45,"market_cap_usd":6765207.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null}],"next_cursor":null}